REFERENCES
[1] Samotij D, Nedoszytko B, Bartosińska J, et al. Pathogenesis of psoriasis in the ”omic” era. Part I. Epidemiology, clinical manifestation, immunological and neuroendocrine disturbances. Postepy Dermatol Alergol. 2020. 37(2): 135-153.
[2] Griffiths C, Armstrong AW, Gudjonsson JE, Barker J. Psoriasis. Lancet. 2021. 397(10281): 1301-1315.
[3] Liang Y, Sarkar MK, Tsoi LC, Gudjonsson JE. Psoriasis: a mixed autoimmune and autoinflammatory disease. Curr Opin Immunol. 2017. 49: 1-8.
[4] Rajkovic I, Dragicevic A, Vasilijic S, et al. Differences in T-helper polarizing capability between human monocyte-derived dendritic cells and monocyte-derived Langerhans’-like cells. Immunology. 2011. 132(2): 217-25.
[5] Hugh JM, Weinberg JM. Update on the pathophysiology of psoriasis. Cutis. 2018. 102(5S): 6-12.
[6] Kim TG, Kim DS, Kim HP, Lee MG. The pathophysiological role of dendritic cell subsets in psoriasis. BMB Rep. 2014. 47(2): 60-8.
[7] Jianbin W, Qihan L. Langerhans cells and viral infections. Microbes and Infections. 2018. 13(4): 250-256.
[8] Nishibu A, Ward BR, Jester JV, Ploegh HL, Boes M, Takashima A. Behavioral responses of epidermal Langerhans cells in situ to local pathological stimuli. J Invest Dermatol. 2006. 126(4): 787-96.
[9] Kubo A, Nagao K, Yokouchi M, Sasaki H, Amagai M. External antigen uptake by Langerhans cells with reorganization of epidermal tight junction barriers. J Exp Med. 2009. 206(13): 2937-46.
[10] Roake JA, Rao AS, Morris PJ, Larsen CP, Hankins DF, Austyn JM. Dendritic cell loss from nonlymphoid tissues after systemic administration of lipopolysaccharide, tumor necrosis factor, and interleukin 1. J Exp Med. 1995. 181(6): 2237-47.
[11] Kissenpfennig A, Henri S, Dubois B, et al. Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity. 2005. 22(5): 643-54.
[12] Tang A, Amagai M, Granger LG, Stanley JR, Udey MC. Adhesion of epidermal Langerhans cells to keratinocytes mediated by E-cadherin. Nature. 1993. 361(6407): 82-5.
[13] Price AA, Cumberbatch M, Kimber I, Ager A. Alpha 6 integrins are required for Langerhans cell migration from the epidermis. J Exp Med. 1997. 186(10): 1725-35.
[14] Roediger B, Ng LG, Smith AL, Fazekas de St Groth B, Weninger W. Visualizing dendritic cell migration within the skin. Histochem Cell Biol. 2008. 130(6): 1131-46.
[15] Sharma A, Upadhyay DK, Gupta GD, Narang RK, Rai VK. IL-23/Th17 Axis: A Potential Therapeutic Target of Psoriasis. Curr Drug Res Rev. 2022. 14(1): 24-36.
[16] Yao DN, Lu CJ, Wen ZH, et al. Oral PSORI-CM01, a Chinese herbal formula, plus topical sequential therapy for moderate-to-severe psoriasis vulgaris: pilot study for a double-blind, randomized, placebo-controlled trial. Trials. 2016. 17(1): 140.
[17] Leng L. Therapeutic effect of PSORI-CM02 on psoriasis model mice and its effect on macrophage polarization. Guangzhou:Guangzhou University of Chinese medicine,2017.
[18] Meng L. Clinical observation and mechanism exploration of PSORI-CM02、Yinxieling tablet on stable plaque psoriasis. Guangzhou:Guangzhou University of Chinese Medicine,2018.
[19] Yue L, Ailin W, Jinwei Z, et al. PSORI-CM02 ameliorates psoriasis in vivo and in vitro by inducing autophagy via inhibition of the PI3K/Akt/mTOR pathway. Phytomedicine. 2019. 64: 153054.
[20] Wu DH, Zhang MM, Li N, et al. PSORI-CM02 alleviates IMQ-induced mouse dermatitis via differentially regulating pro- and anti-inflammatory cytokines targeting of Th2 specific transcript factor GATA3. Biomed Pharmacother. 2019. 110: 265-274.
[21] MacDonald A, Burden AD. Psoriasis: advances in pathophysiology and management. Postgrad Med J. 2007. 83(985): 690-7.
[22] Kamiya K, Kishimoto M, Sugai J, Komine M, Ohtsuki M. Risk Factors for the Development of Psoriasis. Int J Mol Sci. 2019. 20(18).
[23] Mease PJ, Boehncke WH, Gladman DD. Prologue: 2013 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). JOURNAL OF RHEUMATOLOGY. 2013. 40(8): 1407-9.
[24] Meng L. Clinical observation and mechanism exploration of PSORI-CM02、Yinxieling tablet on stable plaque psoriasis. Guangzhou:Guangzhou University of Chinese Medicine,2018.
[25] Shortman K, Liu YJ. Mouse and human dendritic cell subtypes. Nat Rev Immunol. 2002. 2(3): 151-61.
[26] Malissen B, Tamoutounour S, Henri S. The origins and functions of dendritic cells and macrophages in the skin. Nat Rev Immunol. 2014. 14(6): 417-28.
[27] Yoshiki R, Kabashima K, Honda T, et al. IL-23 from Langerhans cells is required for the development of imiquimod-induced psoriasis-like dermatitis by induction of IL-17A-producing γδ T cells. J Invest Dermatol. 2014. 134(7): 1912-1921.
[28] Rendon A, Schäkel K. Psoriasis Pathogenesis and Treatment. Int J Mol Sci. 2019. 20(6).
[29] Oikawa T, Yamada T, Kihara-Negishi F, et al. The role of Ets family transcription factor PU.1 in hematopoietic cell differentiation, proliferation and apoptosis. Cell Death Differ. 1999. 6(7): 599-608.
[30] Chopin M, Seillet C, Chevrier S, et al. Langerhans cells are generated by two distinct PU.1-dependent transcriptional networks. J Exp Med. 2013. 210(13): 2967-80.
[31] Eaton LH, Mellody KT, Pilkington SM, Dearman RJ, Kimber I, Griffiths C. Impaired Langerhans cell migration in psoriasis is due to an altered keratinocyte phenotype induced by interleukin-17. Br J Dermatol. 2018. 178(6): 1364-1372.
[32] Ortner D, Tripp CH, Komenda K, et al. Langerhans cells and NK cells cooperate in the inhibition of chemical skin carcinogenesis. Oncoimmunology. 2017. 6(2): e1260215.
[33] Olguín-Alor R, de la Fuente-Granada M, Bonifaz LC, Antonio-Herrera L, García-Zepeda EA, Soldevila G. A Key Role for Inhibins in Dendritic Cell Maturation and Function. PLoS One. 2016. 11(12): e0167813.
[34] Antonopoulos C, Cumberbatch M, Mee JB, et al. IL-18 is a key proximal mediator of contact hypersensitivity and allergen-induced Langerhans cell migration in murine epidermis. J Leukoc Biol. 2008. 83(2): 361-7.
[35] Deckers J, Hammad H, Hoste E. Langerhans Cells: Sensing the Environment in Health and Disease. Front Immunol. 2018. 9: 93.